The San Diego Chapter of JDRF will bring over 400 guests together for One Red Hot Night at the 15^th Annual Promise Ball on Saturday, May 10, 2014 in an effort to raise over $725,000 for type 1 diabetes (T1D) research. The event has raised over $13 million for T1D research over the past 14 years.

The Promise Ball is a premiere San Diego black-tie event held at the Hilton San Diego Bayfront. The evening will feature a silent and live auction, a gourmet dinner and special entertainment provided by The Red Hot Band, LA’s hottest, high-energy, top-40 show band!

The evening will also feature special tributes to the Lehrer Family, Dexcom and its CEO, Terry Gregg for their support of T1D research.

The Promise Ball is JDRF’s largest fundraising event in San Diego and supports the world class research that is moving science forward to cure, better treat and prevent T1D. “From regeneration and immune therapies to prevention therapies and the pursuit of an artificial pancreas, we have a lot of exciting areas of research occurring in San Diego” said Sean McParland, Executive Director JDRF San Diego.

San Diego-based institutions utilizing JDRF-funded grants for T1D research include The Salk Institute for Biological Studies, The Scripps Research Institute, Genomics Institute of the Novartis Research Foundation, The La Jolla Institute for Allergy and Immunology and UCSD’s Pediatric Diabetes Research Center. JDRF currently provides over $9 million of funding to local research institutions.

This year’s top sponsors of the Promise Ball include QUALCOMM, the Sycuan Band of the Kumeyaay Nation, Dexcom, and KFMB. Other sponsors include the San Diego Padres and Tandem Diabetes Care. Tickets and tables can be purchased by calling the JDRF office at 858-597-0240 or by Clicking Here.

About JDRF

JDRF is the leader in research leading to a cure for T1D in the world.  It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.
The mission of JDRF is to find a cure for diabetes and its complications through the support of research.  Type 1 diabetes is an autoimmune disease that strikes children and adults, and can be fatal.  Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump – each day, every day of their lives.  And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential and devastating complications, which may include kidney failure, blindness, heart disease, stroke and amputation.Since its founding in 1970 by parents of children with T1D, JDRF has awarded more than $1.7 billion to diabetes research, including $110 million last year. More than 80 percent of JDRF’s expenditures directly support research and research-related education.